• Education
  • Financial Transparency Project
  • Pension Reform
  • Transportation
  • Email Newsletters
  • Reason facebook
  • Reason twitter
  • Reason youtube
Reason Foundation
  • About
    • About Us
    • Contact Us
    • Email Newsletters
    • Events
    • FAQs
    • Jobs & Internships
    • Savas Award
    • Shop
    • Staff
    • Trustees & Officers
  • Experts

      Browse Our Experts

      • Aaron Smith
        Director of Education Reform
      • Adrian Moore
        Vice President of Policy
      • Baruch Feigenbaum
        Senior Managing Director, Transportation Policy
      • Geoff Lawrence
        Research Director
      • Guy Bentley
        Director of Consumer Freedom
      • Leonard Gilroy
        Vice President of Government Reform
      • Robert Poole
        Director of Transportation Policy
      • Vittorio Nastasi
        Director of Criminal Justice Policy
      • View All Experts
  • Topics

      Browse Our Topics

      • Air Traffic Control
      • Annual Highway Report
      • Consumer Freedom
      • Criminal Justice Reform
      • Drug Policy
      • Education
      • Email Newsletters
      • Gov’t Financial Transparency
      • Pension Reform
      • Technology
      • Transportation
      • View All Topics
  • Publications
    • Latest
    • Government Financial Transparency Project
    • Annual Highway Report
    • Annual Pension Report
    • Annual Privatization Report
    • Aviation Newsletter
    • Backgrounders
    • Commentaries
    • Data Visualization
    • Education Newsletter
    • Email Newsletters
    • Pension Reform Newsletter
    • Policy Studies
    • Psychedelics Newsletter
    • Public Schools Without Boundaries
    • Testimony
    • Transportation Newsletter
    • Amicus Briefs
  • Reason.com
  • Donate
    • Donate Online
    • Donate Crypto
    • Ways To Give
    • Torchbearer Society
    • Planned Giving

Topics › Drug Policy › Psychedelics

Psychedelics


  • State psychedelics legalization and policy roundup — March 2024
    State psychedelics legalization and policy roundup — March 2024

    Commentary by Gregory Ferenstein

  • Massachusetts ballot initiative aims to legalize psychedelics
    Massachusetts ballot initiative aims to legalize psychedelics

    Commentary by Gregory Ferenstein

  • Ibogaine treatment for opioid use disorder
    Ibogaine treatment for opioid use disorder

    Policy Brief by Madison Carlino

  • Regulated psilocybin access in Arizona would help treat mental health conditions
    Regulated psilocybin access in Arizona would help treat mental health conditions

    Backgrounder by Leonard Gilroy and Geoffrey Lawrence

  • Nonprofit announces new partnership with Ohio to tackle opioid addiction with ibogaine
    Nonprofit announces new partnership with Ohio to tackle opioid addiction with ibogaine

    Commentary by Gregory Ferenstein and Leonard Gilroy

  • A policy framework for personal psychedelics licenses
    A policy framework for personal psychedelics licenses

    Policy Brief by Gregory Ferenstein

  • Psychedelics Policy Newsletter: Impactful ibogaine study, bill introduced in New Hampshire, and more
    Psychedelics Policy Newsletter: Impactful ibogaine study, bill introduced in New Hampshire, and more

    Psychedelics Policy Newsletter by Gregory Ferenstein

  • State psychedelics policy roundup: January 2024 edition
    State psychedelics policy roundup: January 2024 edition

    Commentary by Gregory Ferenstein

  • New Hampshire proposes a unique approach to medical psychedelics
    New Hampshire proposes a unique approach to medical psychedelics

    Commentary by Gregory Ferenstein

More Psychedelics

  • First
  • Prev
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • Next

Follow

  • Facebook
  • Twitter
  • YouTube
  • RSS

Email Updates

Get weekly updates from Reason.

This field is for validation purposes and should be left unchanged.

More About Reason Foundation

  • About
  • Contact
  • Donate
  • Email Newsletters
  • Events
  • Jobs and Internships
  • Policy Research
  • Reason magazine
  • Shop

Contact

Reason Foundation
5737 Mesmer Ave.
Los Angeles, CA 90230
(310) 391-2245

1630 Connecticut Ave NW
Suite 600
Washington, DC 20009
(202) 986-0916

Privacy Policy
Accessibility

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
Copyright © 2025 Reason Foundation